Evidence map›Paper›PMID 39974112›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Early Imaging Identification of Osteoradionecrosis and Classification Using the Novel ClinRad System: Results from A Retrospective Observational Cohort.

MD Anderson Head and Neck Cancer Symptom Working Group; Collaborators, Jillian Rigert, Zaphanlene Kaffey, Zayne Belal, Lavanya Tripuraneni, Laia Humbert-Vidan, Ariana Sahli, Serageldin Attia, Katherine A Hutcheson, Erin Watson and 9 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

MD Anderson Head and Neck Cancer Symptom Working Group; Collaborators
Jillian RigertThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology.ORCID 0000-0001-5419-980X
Zaphanlene KaffeyThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology.ORCID 0009-0008-7999-5245
Zayne BelalThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology.ORCID 0009-0006-2668-9717
Lavanya TripuraneniThe University of Texas MD Anderson Cancer Center, Department of Head and Neck Surgery.
Laia Humbert-VidanThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology.ORCID 0000-0002-8005-6770
Ariana SahliThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology.ORCID 0000-0003-0562-9468
Serageldin AttiaThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology.
Katherine A HutchesonThe University of Texas MD Anderson Cancer Center, Department of Head and Neck Surgery.ORCID 0000-0003-3710-5706
Erin WatsonDepartment of Dental Oncology, Princess Margaret Cancer Centre, Toronto, ON.ORCID 0000-0002-2096-7732
Andrew HopeRadiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.ORCID 0000-0001-6793-2863
Cem DedeThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology.ORCID 0000-0002-0543-9325
Sudarat Kiat-AmnuayUTHealth Houston School of Dentistry.ORCID 0000-0002-8986-9938
Muhammad WaljiUTHealth Houston School of Dentistry.ORCID 0000-0001-5306-9683
Abdallah S R MohamedThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology.ORCID 0000-0003-2064-7613
Vlad C SandulacheThe Department of Otolaryngology Head and Neck Surgery, Baylor College of Medicine.
Clifton David FullerThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology.ORCID 0000-0002-5264-3994
Stephen Y LaiThe University of Texas MD Anderson Cancer Center, Department of Head and Neck Surgery.ORCID 0000-0001-8301-7286
Amy MorenoThe University of Texas MD Anderson Cancer Center, Department of Radiation Oncology.ORCID 0000-0001-6762-6807

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac deviceR01DE028290 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHRISTODOULEAS, JOHN PAUL, FULLER, CLIFTON DAVID · 2019 to 2023
$4.3M
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular OsteoradionecrosisR01DE025248 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LAI, STEPHEN Y · 2016 to 2020
$2.9M
Longitudinal Spatial-Nonspatial Decision Support for Competing Outcomes in Head and Neck Cancer TherapyR01CA258827 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CANAHUATE, GUADALUPE, FULLER, CLIFTON DAVID · 2021 to 2025
$2.9M
Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-Enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)U01DE032168 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Clifton David Fuller, STEPHEN Y LAI · 2023 to 2026
$2.8M
SCH: Personalized Rescheduling of Adaptive Radiation Therapy for Head & Neck CancerR01CA257814 · NCI · RICE UNIVERSITY · PI FULLER, CLIFTON DAVID, SCHAEFER, ANDREW J · 2021 to 2024
$1.8M
Provider and Patient-generated Remote Oro-Dental Health Electronic Data Capture for Algorithmic Longitudinal Evaluation and Risk-Assessment (PROHEALER)K01DE030524 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MORENO, AMY CATHERINE · 2022 to 2024
$479k
Radiation-specific Automated Dental Dose Distributions via Machine-learning based Mapping for Accurate Predictions of (Peri)odontal Problems (RADMAP)R21DE031082 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MORENO, AMY CATHERINE · 2021 to 2022
$452k
NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA257814NCI NIH HHS R01 CA258827NIDCR NIH HHS K01 DE030524NIDCR NIH HHS R01 DE025248NIDCR NIH HHS R01 DE028290NIDCR NIH HHS R21 DE031082NIDCR NIH HHS U01 DE032168
6 · The paper itself

Abstract

Objective: Osteoradionecrosis of the jaw (ORNJ) is a chronic radiation-associated toxicity that lacks standardized classification criteria and treatment guidelines. Understanding early signs of tissue injury could help us better predict, prevent, and conservatively manage ORN. Our primary aims were to identify initial clinically-detected signs of ORN, determine the frequency of imaging-detected ORNJ, and validate the ability to classify cases using the novel system, ClinRad. Study Design: A retrospective electronic health record review of 91 patients treated for head and neck cancer at The University of Texas MD Anderson Cancer Center with suspected ORN was performed by an Oral Medicine specialist to identify initial signs of ORN. Patients who received reirradiation to the head and neck or did not have enough evidence of ORN were excluded. A descriptive analysis was performed. Results: 51 patients met the inclusion criteria. Half (53%) presented with imaging findings and exposed bone. Imaging findings in the absence of bone exposure were identified in 37%, of which disease progression was observed in 26%. All cases were classifiable using ClinRad. Conclusion: Subclinical signs of bony changes consistent with ORN may be evident on imaging without exposed bone, supporting the use of imaging surveillance. ClinRad provided a mechanism to classify all cases at early onset.

Identifiers

PMID39974112
PMCPMC11838654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.